INSP Stock Recent News
INSP LATEST HEADLINES
Inspire Medical's (INSP) focus on R&D raises optimism about the stock.
Inspire Medical's (INSP) both geographic segments witness strong revenue growth in the first quarter.
While the top- and bottom-line numbers for Inspire (INSP) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Inspire Medical Systems, Inc. (NYSE:INSP ) Q1 2024 Results Conference Call May 7, 2024 5:00 PM ET Company Participants Ezgi Yagci - VP, IR Tim Herbert - Chairman and CEO Rick Buchholz - CFO Conference Call Participants Danielle Antalffy - UBS Travis Steed - Bank of America Adam Maeder - Piper Sandler Kallum Titchmarsh - Morgan Stanley David Rescott - Baird Anthony Petrone - Mizuho Chris Pasquale - Nephron Richard Newitter - Truist Securities Shagun Singh - RBC John Block - Stifel Mike Kratky - Leerink Partners Michael Sarcone - Jefferies Larry Biegelsen - Wells Fargo Michael Polark - Wolfe Research Suraj Kalia - Oppenheimer Operator Good afternoon. My name is [Dilem], and I'll be your conference operator today.
Inspire Medical Systems (INSP) came out with a quarterly loss of $0.34 per share versus the Zacks Consensus Estimate of a loss of $0.63. This compares to loss of $0.53 per share a year ago.
Get a deeper insight into the potential performance of Inspire (INSP) for the quarter ended March 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
MINNEAPOLIS, April 30, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the BofA Securities 2024 Health Care Conference on Tuesday, May 14, 2024.
Inspire Medical's (INSP) focus on R&D raises optimism about the stock.
Inspire (INSP) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
Inspire Medical's (INSP) focus on R&D raises optimism about the stock.